Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yoon Duk Hong
Patient-Reported Outcomes in Orphan Drug Labels Approved by the US FDA
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Beyond the FDA PRO Guidance: Steps Toward Integrating Meaningful Patient-Reported Outcomes Into Regulatory Trials and US Drug Labels
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
From the FDA: Epilepsy Drug Approved
Journal of the American Osteopathic Association, The
Medicine
Alternative Medicine
Complementary
Analysis of the Ultra-Orphan Drugs Approved by the Fda in the Period 1983-2014
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Review on the Drugs Approved by US-FDA and DCGI
TEXILA INTERNATIONAL JOURNAL OF CLINICAL RESEARCH
FDA Reported Use of Patient Experience Data in 2018 Drug Approvals
Therapeutic Innovation and Regulatory Science
Pharmacology
Public Health
Environmental
Toxicology
Pharmaceutics
Occupational Health
Patient-Reported Outcome Claims in European and United States Orphan Drug Approvals
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Drug Development Process and Novel Drugs Approved by FDA for 2017 -18
Applied Clinical Research, Clinical Trials and Regulatory Affairs
Measurement of Patient-Reported Outcomes. 2: Are Current Measures Failing Us?
Journal of Medical Economics
Health Policy
Responder Definition of a Patient-Reported Outcome Instrument for Laryngopharyngeal Reflux Based on the US FDA Guidance
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental